{"id":"W4362587019","doi":"10.1016/s1556-0864(23)00423-9","title":"169P Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"PharmaMar; Castle Biosciences; Daiichi Sankyo Europe; Exelixis; ViewRay; Novocure; Elekta; Varian Medical Systems; Pfizer; Eli Lilly and Company; AstraZeneca; Accuray; LUNGevity Foundation; MedImmune; Mesothelioma Applied Research Foundation","keywords":"Medicine; Olaparib; Atezolizumab; Internal medicine; Oncology; Dysgeusia; Lung cancer; Adverse effect; Radiation therapy; Urology; Cancer; Gastroenterology; Nivolumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001135058,0.001479105,0.002064582,0.0004393265,0.0004110791,0.001270256,0.0008559524,0.00113368,0.006917799],"category_scores_gemma":[0.000814818,0.0005007092,0.001759438,0.0004322817,0.0009174445,0.0008054894,0.0005172966,0.003868097,0.001339521],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001103343,"about_ca_system_score_gemma":0.001709081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001133563,"about_ca_topic_score_gemma":0.002819619,"domain_scores_codex":[0.9996643,0.0001514386,0.00001420825,0.00006478144,0.00002837064,0.00007696348],"domain_scores_gemma":[0.9995267,0.00009733603,0.00006579895,0.00004686465,0.00002337415,0.0002399849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7927284,0.02945855,0.002019525,0.001333482,0.001652129,0.0001608994,0.0001726705,0.00481469,0.02186036,0.0008376013,0.006480041,0.1384817],"study_design_scores_gemma":[0.7443761,0.2427309,0.004970762,0.00006458208,0.000465503,0.0001616559,0.00007253263,0.001373142,0.001574819,0.0006451037,0.00352854,0.00003635577],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838539,0.003291843,0.0008655557,0.001236942,0.0005728005,0.002772687,0.002134012,0.0001979238,0.005074298],"genre_scores_gemma":[0.9786311,0.002977381,0.002740277,0.001799872,0.0003339908,0.003079866,0.003737763,0.00005981903,0.006639983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006917799,"threshold_uncertainty_score":0.02314234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07487591896206015,"score_gpt":0.50855599154978,"score_spread":0.4336800725877199,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}